NIAID Site Search

Ian A. Myles, M.D., M.P.H., is the Staff Clinician for the Epithelial Therapeutics Unit. The unit focuses on how human health is affected by the normal microorganisms that live on our skin (collectively termed the microbiome). Our emphasis is on eczema (also called atopic dermatitis or AD), which is an inflammatory disease of the skin associated with reduced quality of life and high risk of developing asthma, allergic rhinitis, and food allergies.

Last Reviewed: November 29, 2023

Learn how to interpret your NIH summary statement for information about the review, the reviewers’ critiques, and your score.

Last Reviewed: January 8, 2025

NIH and NIAID want to fund more new scientists and have created special programs and funding approaches to meet that goal.

Last Reviewed: August 5, 2020

It's a fact of grant life: most applications do not succeed. If yours is one of them at NIH, you need to first spend some time identifying what went wrong.

Last Reviewed: September 13, 2024

This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in 2006.

Last Reviewed: August 6, 2019

This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in August 2003.

Last Reviewed: August 6, 2019

This document outlines the guidelines for the diagnosis and management of food allergy in the US, specifically for patients, families, and caregivers.

Last Reviewed: July 9, 2019

This policy describes the NIAID requirement for clinical research trials to have written procedures to allow the IoR to independently unblind elements.

Last Reviewed: December 7, 2018

NIH Opening Statement Senate LHHS FY 2019 Hearing: Prepared statement of Lawrence A. Tabak, D.D.S., PH.D., Principal Deputy Director, Office of the Director

Last Reviewed: August 16, 2018

On this 35 th World AIDS Day, the National Institutes of Health (NIH) joins its partners in honoring the lives lost due to the HIV pandemic. For decades, this virus has exacted a tragic toll, affecting people, families, and communities worldwide, threatening social and economic development, and exacerbating stigma, often toward people who already experience discrimination and health disparities

Published: December 1, 2023

Sample application from Mohammad Ayoub Mir

Last Reviewed: August 4, 2017

2021 progress report on NIH strategic plan to develop medical countermeasures against possible terrorist attacks involving radioactive materials.

Last Reviewed: December 30, 2016

Epithelial Therapeutics Unit – work on the interface of environment, the microbiome, and allergic disease

Last Reviewed: September 26, 2022

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

A collection of sample grant applications and other resources provided by NIAID investigators.

Last Reviewed: November 6, 2024

NIH chemical countermeasures research program

Last Reviewed: May 18, 2022

This page explains how principal investigators using live vertebrate animals should adhere to NIH requirements, prepare applications, and manage grants.

Last Reviewed: November 21, 2024

The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public

Last Reviewed: January 11, 2024

The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and

Last Reviewed: February 5, 2024